Teladoc Health, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $123.2m $233.3m $417.9m $553.3m $1.1b $2.0b $2.4b $2.6b $2.6b $2.5b
Revenue from Contract with Customer, Including Assessed Tax $123.2m $233.3m $417.9m $553.3m $1.1b $2.0b $2.4b $2.6b $2.6b $2.5b
Cost of Revenue $32.0m $61.6m $128.7m $184.5m $390.8m $650.3m $744.0m $760.0m $751.3m $771.6m
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization $32.0m $61.6m $128.7m $184.5m $390.8m $650.3m $744.0m $760.0m $751.3m $771.6m
Gross Profit (derived) $91.2m $171.7m $289.2m $368.8m $703.1m $1.4b $1.7b $1.8b $1.8b $1.8b
Operating expenses:
Operating Income (Loss) ($62.7m) ($75.4m) ($70.9m) ($80.4m) ($506.4m) ($265.6m) ($13.7b) ($248.6m) ($1.0b) ($263.0m)
Additional Financial Items
Amortization of Intangible Assets $6.1m $15.3m $31.5m $35.6m $64.7m $195.3m $244.6m $325.9m $363.4m $350.8m
Capitalized Computer Software, Amortization $46.1m $83.0m $133.0m $167.6m
Foreign Currency Transaction Gain (Loss), Realized ($100k) $100k $200k ($600k)
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $13.4b $0 $790.0m $71.8m
Income (Loss) from Continuing Operations before Income Taxes, Domestic $73.7m ($107.7m) ($91.1m) ($95.5m) ($566.3m) ($365.8m) ($13.3b) ($192.7m) ($990.0m) ($232.3m)
Realized Investment Gains (Losses) $5.9m $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($73.7m) ($107.0m) ($97.0m) ($109.5m) ($576.0m) ($384.7m) ($13.7b) ($219.6m) ($993.7m) ($235.5m)
Net Income (Loss) Attributable to Parent ($74.2m) ($106.8m) ($97.1m) ($98.9m) ($485.1m) ($428.8m) ($13.7b) ($220.4m) ($1.0b) ($200.3m)
Net Income (Loss) Available to Common Stockholders, Basic ($74.2m)
Earnings Per Share, Basic ($1.38) ($5.36) ($2.73) ($84.60) ($1.34) ($5.87) ($1.14)
Earnings Per Share, Diluted ($1.38) ($5.36) ($2.73) ($84.60) ($1.34) ($5.87) ($1.14)
Weighted Average Number of Shares Outstanding, Basic 156.9m 161.5m 164.6m 170.6m 176.2m
Weighted Average Number of Shares Outstanding, Diluted 156.9m 161.5m 164.6m 170.6m 176.2m
Research and Development Expense $21.8m $34.5m $54.4m $64.6m $164.9m $311.9m $333.6m $348.5m $307.3m $277.9m
General and Administrative Expense $48.6m $79.8m $116.9m $157.7m $497.8m $438.0m $449.9m $464.7m $435.5m $431.9m
Other Nonoperating Income (Expense) $5.1m ($859k) $4.4m ($6.0m) $10.4m
Interest Expense (non-operating) $23.8m $19.7m
Business Combination, Acquisition Related Costs $7.0m $13.2m $10.4m $6.6m $88.2m $26.6m $15.6m $21.1m $1.7m $9.0m
Costs and Expenses $633.7m $1.6b $2.3b $16.1b $2.9b $3.6b $2.8b
Current Income Tax Expense (Benefit) $366k $2.0m $277k ($322k) $3.2m $4.0m $2.7m $8.7m $6.2m
Interest Expense $81.1m $21.9m $22.3m $23.8m $19.7m
Marketing and Advertising Expense $34.7m $57.7m $85.1m $109.7m $226.1m $416.7m $623.5m $688.9m $705.8m $653.4m
Restructuring Costs $0 $0 $7.4m $16.9m $20.4m $18.8m
Selling Expense $26.2m $38.0m $59.2m $64.9m $154.1m $250.6m $227.2m $213.8m $205.0m $194.5m
Share-based Payment Arrangement, Expensed and Capitalized, Amount $221.0m $158.7m $88.0m
Income Tax Expense (Benefit) $510k ($225k) $118k ($10.6m) ($90.9m) $44.1m ($3.8m) $760k $7.6m ($35.2m)
Interest Income (Expense), Net ($2.6m) ($17.5m) ($26.1m) ($29.0m) ($60.5m) ($80.4m) ($9.3m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.